Using tissue engineered cartilage to investigate diabetes-induced osteoarthritis by Roberts, Cameron & Henstock, James
  
 
 
Using tissue engineered cartilage to investigate diabetes-induced 
osteoarthritis 
C.A. Roberts1, J.R. Henstock1 
Presenting Author: J.R. Henstock j.r.henstock@liverpool.ac.uk 
1 Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool UK 
 
INTRODUCTION: People with diabetes have 
more than double the incidence of osteoarthritis.  
Despite the huge and increasing global 
incidences of both diabetes and osteoarthritis, 
research on diabetes-induced osteoarthritis (DiOA) 
as a specific condition is very limited, partly 
because neither animal models nor traditional cell 
culture are capable of fully replicating the disease 
state. We have generated a lab-grown tissue 
engineered human model of diabetic osteoarthritis 
to investigate the effects of high glucose 
concentrations on chondrocytes, uncover the DiOA 
mechanism and determine the efficacy of several 
interventional treatments (including ascorbic acid 
and aspirin) to reduce cartilage damage in people 
living with diabetes and hyperglycemia. 
 
METHODS: Tissue engineered cartilage 
combines human chondrocytes with an agarose- or 
alginate-based hydrogel to support chondrocytes in 
a transparent matrix, recreating the actual cell 
density and tissue function of native adult cartilage.  
The TE cartilage was cultured in either ‘normal’ 
1g/l (5mM) glucose, high (4.5g/l; 25mM) or very 
high (10g/l; 55mM) glucose concentrations for 21 
days. Media assays were performed to determine 
the synthesis and secretion of collagen, 
glycosaminoglycans and total protein by the 
chondrocytes. Interventional compounds were 
added to the media to test the targeted protective 
effects of ascorbic acid and aspirin (acetylsalicylic 
acid) on chondrocyte ECM production. 
 
RESULTS: Chondrocytes survived in very high 
glucose concentrations (>10mg/ml) with little loss 
in viability, but their production of collagen and 
other proteins over 21 days was inhibited by high 
glucose (fig 1 a-c). The production of glycosamino-
glycans (sGAGs) was unaffected even in very high 
glucose-containing media (fig. 1.d). Supple-
mentation with ascorbic acid (vitamin C), 
resveratrol and tocopherol (vitamin E) mitigated 
the effects of hyperglycemia, whilst high doses of 
acetylsalicylic acid (aspirin) were shown to 
completely reverse the disease phenotype and 
return collagen production to normal levels.  
 
 
 
Figure 1: Collagen secretion (A) and accumulation 
in the tissue engineered cartilage (B) was ~40% 
lower in high glucose media compared to low 
glucose controls after 21 days. Over this time, high 
glucose levels of 10g/l caused a significant 
reduction in protein secretion in comparison to 
controls (C), whilst the chondrocytes secretion of 
sGAGs was unaffected by the excess of glucose 
(D). Error bars show SEM, n=6 in A, n=16 in 
C&D; *** p<0.001. 
 
DISCUSSION & CONCLUSIONS: Diabetes-
induced osteoarthritis may be a unique type of OA 
with a treatable cause. Our research focusses on 
understanding the mechanism for the condition and 
evaluating dietary supplements that may mitigate 
or reverse cartilage damage caused by persistent 
hyperglycaemia. The role of mitochondria as key 
regulators of the disease is currently under 
investigation. 
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